- Klíčová slova
- resekce nádoru, kontroverze,
- MeSH
- endoskopie klasifikace metody MeSH
- kraniofaryngeom * chirurgie diagnóza terapie MeSH
- lidé MeSH
- magnetická rezonanční tomografie metody MeSH
- management nemoci MeSH
- neurochirurgické výkony * klasifikace metody přístrojové vybavení MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- přehledy MeSH
INTRODUCTION: In the era of personalized medicine and treatment optimization, use of immune biomarkers holds promise for estimating the prognosis of patients with head and neck squamous cell carcinoma (HNSCC) undergoing definitive treatment. METHODS: To evaluate the prognostic potential of immune biomarkers, we conducted a prospective monocentric cohort study with loco-regionally advanced HNSCC patients indicated for definitive radiotherapy/radiochemotherapy at the Department of Oncology, Ostrava University Hospital, Czech Republic, between June 2020 and August 2023. We focused on the expression of programmed death ligand 1 (PD-L1) and tumor-infiltrating lymphocytes (TILs) relative to overall survival (OS) and specific survival rates. Associations between biomarkers and survival rates were assessed by crude and adjusted hazard ratios (cHR, aHR, respectively) obtained from Cox proportional hazards regression. RESULTS: Among a total of 55 patients within a median follow-up of 19.7 months, there were 21 (38.2%) all-cause deaths and 15 (27.3%) cancer-related deaths. An overall survival (OS) rate of 61.8% and a disease-specific survival (DSS) rate of 72.7% were recorded. A significant association between survival rates and a ≥10% difference in PD-L1 expression on immune versus tumor cells (high PD-L1IC expression) was documented regardless of the type of analysis (univariate or multivariate). In addition, a stronger association was confirmed for OS and the composite biomarker high PD-L1IC expression along with either median-higher CD8+ TIL count or increased TIL density ≥30%, as indicated by an aHR of 0.08 (95% CI, 0.01 to 0.52) and 0.07 (95% CI, 0.01 to 0.46), respectively. Similar results were demonstrated for other specific survival rates. DISCUSSION: The early outcomes of the present study suggest the utility of a strong prognostic factor involving a composite biomarker high PD-L1IC expression along with increased TIL density in HNSCC patients undergoing definitive radiotherapy and radiochemotherapy. TRIAL REGISTRATION: The study is registered with Clinicaltrials.gov. - NCT05941676.
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: This study was designed to evaluate the possibility of predicting the minimum size of septal resection for safe tumor extraction in transnasal paraseptal pituitary adenoma resection from preoperative computed tomography scans. METHODS: A retrospective CT scan analysis was performed on 20 patients who underwent endoscopic pituitary surgery at the University Hospital in Ostrava. Virtual insertion of the straight instrument into the sphenoid cavity was simulated using a CT scan. The minimum septal resection size was predicted and compared to various diameters in the nasal cavity. The results were then compared with cadaveric dissections, in which septal resections were performed at 1 cm and 2 cm distances from the anterior sphenoid wall. The association between cadaver dissections and CT scan results was studied. RESULTS: A total of 20 patients who underwent endoscopic transnasal surgery for pituitary adenoma between the years 2020 and 2021 were enrolled in the study. The mean virtual posterior septal size resection needed to reach the medial edge of the ICA with the straight instrument, without infracturing the nasal septum, was 13.2 mm. In cadavers with a 1 cm posterior septal resection, the medial edge of the ICA was reached with the straight instrument. In 2 cm resections, it was possible to reach beyond the lateral edge of the ICA. CONCLUSION: There is no significant correlation between the minimum septal size resection and measured diameters in the nasal cavity. According to our study, a 1 cm resection is sufficient for a non-extended pituitary tumor extraction. More extensive septal resections allow for better maneuverability and overview in the surgical field.
- MeSH
- adenom * diagnostické zobrazování chirurgie patologie MeSH
- endoskopie metody MeSH
- lidé MeSH
- nádory hypofýzy * diagnostické zobrazování chirurgie patologie MeSH
- nosní dutina diagnostické zobrazování chirurgie patologie MeSH
- počítačová rentgenová tomografie MeSH
- retrospektivní studie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- MeSH
- otorinolaryngologie MeSH
- Publikační typ
- biografie MeSH
- O autorovi
- Komínek, Pavel, 1958- Autorita
- MeSH
- elektrokoagulace * klasifikace metody škodlivé účinky MeSH
- epistaxe * patologie terapie MeSH
- lidé MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- přehledy MeSH
- MeSH
- arterie chirurgie MeSH
- chirurgie nosu * metody škodlivé účinky MeSH
- epistaxe * chirurgie MeSH
- lidé MeSH
- sinus ethmoidalis chirurgie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- přehledy MeSH
- MeSH
- arterie chirurgie MeSH
- chirurgie nosu * metody škodlivé účinky MeSH
- epistaxe * chirurgie MeSH
- lidé MeSH
- sinus ethmoidalis chirurgie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- přehledy MeSH
- MeSH
- arteria carotis externa chirurgie MeSH
- arteria maxillaris chirurgie MeSH
- chirurgie nosu * klasifikace metody škodlivé účinky MeSH
- epistaxe * chirurgie MeSH
- lidé MeSH
- ligace metody škodlivé účinky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- přehledy MeSH
- MeSH
- epistaxe * chirurgie etiologie ošetřování MeSH
- lidé MeSH
- otorinolaryngologie metody trendy MeSH
- týmová péče o pacienty MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- přehledy MeSH
- MeSH
- arteria carotis interna chirurgie patologie MeSH
- baze lební chirurgie MeSH
- chirurgie nosu škodlivé účinky MeSH
- chirurgie operační škodlivé účinky MeSH
- epistaxe * etiologie klasifikace prevence a kontrola terapie MeSH
- krvácení při operaci * prevence a kontrola MeSH
- lidé MeSH
- pooperační krvácení MeSH
- poranění arteria carotis chirurgie patologie prevence a kontrola MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- přehledy MeSH